Opthea Limited
World Rank (Jan-05-2024)
16,232
Market Cap (Jan-05-2024)
0.277 Billion USD
World Rank (Jul-30-2023)
18,598
Market Cap (Jul-30-2023)
0.180 Billion USD
World Rank (Dec-25-2022)
16,897
Market Cap (Dec-25-2022)
0.247 Billion USD
World Rank (Jan-07-2022)
16,291
Market Cap (Jan-07-2022)
0.32 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-12 Million USD
Annual Results for Period Ending
Jun-2020 ending year
Company Profile
Opthea is Biotechnology company with headquarters is in Australia.
Opthea is committed to improving vision in patients suffering from retinal eye diseases.
They are developing a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to be used in conjunction with existing standard of care anti-VEGF-A therapies.
Company Website